Avance Biosciences specializes in assay development, validation, and sample testing services supporting our clients for their drug development initiatives and GMP manufacturing activities. We are a leader in applying state-of-art technologies, such as next generation sequencing (NGS) and digital droplet PCR (ddPCR), to improve the effectiveness and efficiency of biologic tests.
Join Us At CAR-TCR Summit – Sept 10-13 – Boston, MA
Returning to Boston for the 5th year, the CAR-TCR Summit is a world-renowned conference bringing together over 1000 industry leaders developing CAR-TCR based therapies. Join pharma, biotech, regulatory bodies, academia, solution and service providers to discuss the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders
Avance offers cell therapy genomic testing services supporting CAR/TCR development and manufacturing
Avance Biosciences provides assay development, validation and sample testing services for lot release of manufactured T-cells and for monitoring copy number of target genes in patients’ blood during clinical trials.
Copy Number Analysis (VCN) for Inserted Genes
Replication Competent Lentivirus (RCL) Testing
Preclinical QPCR Biodistribution Studies
Quantification of mRNA in Biological Samples
Testing of Transgene Copy Number in Human Blood